Federated Hermes’s Protalix BioTherapeutics PLX Stock Holding History

Federated Hermes’s Portfolio PLX Stock Details PLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,761	Closed	-$12.1K	–	2199
2023 Q1	$12.1K	Hold	5,761	–	–	﹤0.01%	1858
2022 Q4	$7.89K	Hold	5,761	–	–	﹤0.01%	1891
2022 Q3	$6K	Hold	5,761	–	–	﹤0.01%	1875
2022 Q2	$6K	Hold	5,761	–	–	﹤0.01%	1883
2022 Q1	$6K	Hold	5,761	–	–	﹤0.01%	1939
2021 Q4	$5K	Hold	5,761	–	–	﹤0.01%	1992
2021 Q3	$8K	Hold	5,761	–	–	﹤0.01%	2006
2021 Q2	$11K	Hold	5,761	–	–	﹤0.01%	1977
2021 Q1	$26K	Hold	5,761	–	–	﹤0.01%	1932
2020 Q4	$21K	Hold	5,761	–	–	﹤0.01%	1903
2020 Q3	$22K	Hold	5,761	–	–	﹤0.01%	1884
2020 Q2	$22K	Hold	5,761	–	–	﹤0.01%	1853
2020 Q1	$14K	Hold	5,761	–	–	﹤0.01%	1827
2019 Q4	$19K	Hold	5,761	–	–	﹤0.01%	1841
2019 Q3	$12K	Hold	5,761	–	–	﹤0.01%	1868
2019 Q2	$27K	Hold	5,761	–	–	﹤0.01%	1767
2019 Q1	$25K	Hold	5,761	–	–	﹤0.01%	1744
2018 Q4	$18K	Hold	5,761	–	–	﹤0.01%	1789
2018 Q3	$42K	Hold	5,761	–	–	﹤0.01%	1758
2018 Q2	$25K	Hold	5,761	–	–	﹤0.01%	1773
2018 Q1	$31K	Sell	5,761 -16,410	-74%	-$88.3K	﹤0.01%	1701
2017 Q4	$147K	Sell	22,171 -172,397	-89%	-$1.14M	﹤0.01%	1554
2017 Q3	$1.13M	Hold	194,568	–	–	﹤0.01%	1163
2017 Q2	$1.63M	Sell	194,568 -19,775	-9%	-$166K	﹤0.01%	1012
2017 Q1	$2.92M	Hold	214,343	–	–	0.01%	754
2016 Q4	$954K	Buy	+214,343	New	+$954K	﹤0.01%	1143
2015 Q4	–	Sell	-650,362	Closed	-$7.67M	–	2138
2015 Q3	$7.67M	Sell	650,362 -95,295	-13%	-$1.12M	0.02%	476
2015 Q2	$14.5M	Sell	745,657 -159,303	-18%	-$3.11M	0.04%	391
2015 Q1	$16.1M	Sell	904,960 -29,490	-3%	-$525K	0.05%	352
2014 Q4	$17.2M	Sell	934,450 -18,000	-2%	-$331K	0.05%	324
2014 Q3	$23M	Sell	952,450 -41,834	-4%	-$1.01M	0.07%	264
2014 Q2	$36.3M	Sell	994,284 -29,717	-3%	-$1.08M	0.11%	178
2014 Q1	$46.9M	Buy	1,024,001 +1,471	+0.1%	+$67.4K	0.16%	128
2013 Q4	$39.8M	Sell	1,022,530 -20,217	-2%	-$786K	0.14%	148
2013 Q3	$47.2M	Buy	1,042,747 +5,398	+0.5%	+$245K	0.18%	117
2013 Q2	$50.9M	Buy	+1,037,349	New	+$50.9M	0.2%	104